Archives
Nestle Cuts Sales Forecast as Shoppers Reject Price Hikes
Nestle has lowered its sales forecast for the year to 3% growth, down from 4%, as consumers reject price hikes on its products, leading to a 5% drop in its shares.
AstraZeneca Expects Strong Profit as Demand Gets High for Cancer and Rare Disease Drugs
AstraZeneca has raised its full-year sales and profit forecast due to strong demand for its drugs for cancer, rare diseases, and heart disease.
Australian Judge Dismisses Lawsuit vs. Bayer Over Claims Weedkiller Causes Blood Cancer
The Australian Federal Court dismissed a class action lawsuit that claimed German pharmaceutical and chemicals company Bayer’s glyphosate-based herbicide Roundup could cause a type of blood cancer, which gave the firm a respite after facing similar cases in the United States.
Biotech Boss Jacob VanLandingham Pleads Guilty Over Welfare Fund Case
Biotech executive Jacob VanLandingham pleaded guilty to a fraud charge after allegedly improperly using welfare funds intended to develop a concussion drug in the largest public corruption case in the history of the state of Mississippi.